Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELAAT: Immediate vs Deferred Goserelin for Recurrent Prostate Cancer
NCT00439751Phase 3Completed
- Sponsor
- Ontario Clinical Oncology Group
- Start
- Apr 2007
- Primary completion
- Dec 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin in prostate cancer (PCa), sponsored by Ontario Clinical Oncology Group. Started Apr 2007; status: completed.
02
Drugs
goserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00439751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439751.